| Aug 10, 2021 (view filing) | Aug 6-10 | 4 days | Pierce Robert HamiltonChief Scientific Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −79.8K | $7.12 | −$568.3K | −83.3%16.0K after | 3 lotsThis row combines 3 trades of the same kind from one filing. The price is the value-weighted average. |
| Aug 12, 2021 (view filing) | Aug 11 | 1 day | Pierce Robert HamiltonChief Scientific Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −16.0K | $7.34 | −$117.7K | −100.0%0 after | |
| Dec 13, 2021 (view filing) | Dec 9-10 | 4 days | Ricks Thomas GDirector | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +40.0K | $6.24 | +$249.6K | +13.3%341.8K after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Dec 20, 2021 (view filing) | Dec 16 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.9K | $5.25 | +$57.4K | +0.2%4.82M after | |
| Dec 20, 2021 (view filing) | Dec 16 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.9K | $5.25 | +$57.4K | +0.2%4.82M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +117 | $5.29 | +$618.93 | 0.0%4.82M after | |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +117 | $5.29 | +$618.93 | 0.0%4.82M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Dec 23, 2021 (view filing) | Dec 23 | Same day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +11.0K | $5.27 | +$58.0K | +0.2%4.83M after | |
| Dec 23, 2021 (view filing) | Dec 23 | Same day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +11.0K | $5.27 | +$58.0K | +0.2%4.83M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +3.71K | $5.30 | +$19.7K | +0.1%4.84M after | |
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +3.71K | $5.30 | +$19.7K | +0.1%4.84M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Dec 29, 2021 (view filing) | Dec 28 | 1 day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +11.3K | $5.28 | +$59.6K | +0.2%4.85M after | |
| Dec 29, 2021 (view filing) | Dec 28 | 1 day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +11.3K | $5.28 | +$59.6K | +0.2%4.85M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Dec 30, 2021 (view filing) | Dec 29 | 1 day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +69.0K | $4.98 | +$343.6K | +1.4%4.92M after | |
| Dec 30, 2021 (view filing) | Dec 29 | 1 day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +69.0K | $4.98 | +$343.6K | +1.4%4.92M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +1.13K | $4.85 | +$5.47K | 0.0%4.92M after | |
| Jan 3, 2022 (view filing)9:38 AM ET | Dec 30, 2021 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +1.13K | $4.85 | +$5.47K | 0.0%4.92M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 11, 2022 (view filing) | Jan 10 | 1 day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.0K | $5.28 | +$52.8K | +0.2%4.93M after | |
| Jan 11, 2022 (view filing) | Jan 10 | 1 day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.0K | $5.28 | +$52.8K | +0.2%4.93M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 13, 2022 (view filing) | Jan 11-12 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +20.0K | $5.20 | +$104.2K | +0.4%4.95M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 13, 2022 (view filing) | Jan 11-12 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +20.0K | $5.20 | +$104.2K | +0.4%4.95M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 18, 2022 (view filing) | Jan 13-14 | 5 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +26.2K | $5.10 | +$133.4K | +0.5%4.98M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 18, 2022 (view filing) | Jan 13-14 | 5 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +26.2K | $5.10 | +$133.4K | +0.5%4.98M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.0K | $5.08 | +$50.8K | +0.2%4.99M after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.0K | $5.08 | +$50.8K | +0.2%4.99M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 21, 2022 (view filing) | Jan 19-20 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.2K | $5.10 | +$154.3K | +0.6%5.02M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 21, 2022 (view filing) | Jan 19-20 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.2K | $5.10 | +$154.3K | +0.6%5.02M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 25, 2022 (view filing) | Jan 21-24 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +47.4K | $4.82 | +$228.5K | +0.9%5.06M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 25, 2022 (view filing) | Jan 21-24 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +47.4K | $4.82 | +$228.5K | +0.9%5.06M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 27, 2022 (view filing) | Jan 25-26 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +50.0K | $4.72 | +$235.8K | +1.0%5.11M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 27, 2022 (view filing) | Jan 25-26 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +50.0K | $4.72 | +$235.8K | +1.0%5.11M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 31, 2022 (view filing) | Jan 27-28 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +15.0K | $4.26 | +$63.8K | +0.3%5.13M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 31, 2022 (view filing) | Jan 27-28 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +15.0K | $4.26 | +$63.8K | +0.3%5.13M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 8, 2022 (view filing) | Feb 3-8 | 5 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.0K | $4.53 | +$135.8K | +0.6%5.16M after | 3 lotsThis row combines 3 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 8, 2022 (view filing) | Feb 3-8 | 5 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.0K | $4.53 | +$135.8K | +0.6%5.16M after | 3 lotsThis row combines 3 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 14, 2022 (view filing) | Feb 10-11 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.5K | $4.45 | +$77.9K | +0.3%5.18M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 14, 2022 (view filing) | Feb 10-11 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.5K | $4.45 | +$77.9K | +0.3%5.18M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 16, 2022 (view filing) | Feb 14 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.0K | $4.18 | +$41.8K | +0.2%5.19M after | |
| Feb 16, 2022 (view filing) | Feb 16 | Same day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.55K | $4.25 | +$10.8K | 0.0%5.19M after | |
| Feb 16, 2022 (view filing) | Feb 14-16 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +12.6K | $4.19 | +$52.6K | +0.2%5.19M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 22, 2022 (view filing) | Feb 17-18 | 5 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +19.9K | $4.02 | +$80.2K | +0.4%5.21M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 22, 2022 (view filing) | Feb 17-18 | 5 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +19.9K | $4.02 | +$80.2K | +0.4%5.21M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 24, 2022 (view filing) | Feb 23-24 | 1 day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.5K | $3.65 | +$64.0K | +0.3%5.23M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 24, 2022 (view filing) | Feb 23-24 | 1 day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.5K | $3.65 | +$64.0K | +0.3%5.23M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 28, 2022 (view filing) | Feb 25 | 3 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.50K | $3.65 | +$9.13K | 0.0%5.23M after | |
| Feb 28, 2022 (view filing) | Feb 25 | 3 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.50K | $3.65 | +$9.13K | 0.0%5.23M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Mar 1, 2022 (view filing) | Feb 28-Mar 1 | 1 day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.50K | $3.60 | +$9.00K | 0.0%5.23M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Mar 1, 2022 (view filing) | Feb 28-Mar 1 | 1 day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.50K | $3.60 | +$9.00K | 0.0%5.23M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Apr 21, 2022 (view filing) | Feb 18, 2021 | 427 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +752 | $19.75 | +$14.9K | 0.0%4.69M after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing. |
| Apr 21, 2022 (view filing) | Mar 23, 2021 | 394 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +9.50K | $14.34 | +$136.2K | +0.2%4.80M after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing. |
